FDA Inspection
Granules India LimitedGranules India Limited – FDA Inspection, Feb 14, 2020
Record Details
This FDA Inspection record concerns Granules India Limited, with an inspection on February 14, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Granules India Limited
- Inspection Date
- February 14, 2020
- Product Type
- Drugs
View Company Profile
ID · e944d7ad-7bc6-4e13-834e-8dd487037e68
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Granules India Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2024 | Not classified | Office of Inspections and Investigations | |
| January 13, 2023 | Not classified | Office of Inspections and Investigations | |
| March 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 13, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Granules India Limited
- FDA Inspection 1248503 - 2024-09-06
- FDA Inspection 1197727 - 2023-01-13
- FDA Inspection 1050607 - 2018-03-23
- FDA Inspection 992723 - 2016-10-14
- FDA Inspection 918291 - 2015-03-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.